Author:
Sava Gianni,Zorzet Sonia,Perissin Laura,Pacor Sabrina,Lassiani Lucia,Nisi Carlo,Varnavas Antonio
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference28 articles.
1. Audette SRC, Connors TA, Mandel GH, Merai K, Ross WCJ (1973) Studies on the mechanism of action of the tumour inhibitory triazenes. Biochem Pharmacol 22:1856
2. Connors TA, Goddard PM, Merai K, Ross WCJ, Wilman DEV (1976) Tumour inhibitory triazenes: structural requirements for an active metabolite. Biochem Pharmacol 25:241
3. Fioretti MC, Nardelli B, Bianchi R, Nisi C, Sava G (1981) Antigenic changes of a murine lymphoma by in vivo treatment with triazene derivatives. Cancer Immunol Immunother 11:283
4. Giraldi T (1984) DM-COOK. Drugs Future 9:503
5. Giraldi T, Nisi C, Sava G (1975) Investigation on the oxidativeN-demethylation of aryltriazenes in vitro. Biochem Pharmacol 24: 1793